| 2013 | Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors | Bergman, A; Andersson, A-M; Becher, G; van den Berg, M; Blumberg, B; Bjerregaard, P; Bornehag, C-G; Bornman, R; Brandt, I; Brian, JV; Casey, SC; Fowler, PA; Frouin, H; Giudice, LC; Iguchi, T; Hass, U; Jobling, S; Juul, A; Kidd, KA; Kortenkamp, A; Lind, M; Martin, OV; Muir, D; Ochieng, R; Olea, N; Norrgren, L; Ropstad, E; Ross, PS; Ruden, C; Scheringer, M; Skakkebaek, NE; Soder, O; Sonnenschein, C; Soto, A; Swan, S; Toppari, J; Tyler, CR; Vandenberg, LN; Vinggaard, AM; Wiberg, K; Zoeller, RT |
| 2013 | Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, SJE; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
